|
Atomistry » Zinc » PDB 5seq-5sft » 5sfh | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Zinc » PDB 5seq-5sft » 5sfh » |
Zinc in PDB 5sfh: Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-AmineEnzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-Amine
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-Amine:
3.1.4.17; Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-Amine, PDB code: 5sfh
was solved by
C.Joseph,
A.Flohr,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 5sfh:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-Amine also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-Amine
(pdb code 5sfh). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-Amine, PDB code: 5sfh: Jump to Zinc binding site number: 1; 2; 3; 4; Zinc binding site 1 out of 4 in 5sfhGo back to Zinc Binding Sites List in 5sfh
Zinc binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-Amine
Mono view Stereo pair view
Zinc binding site 2 out of 4 in 5sfhGo back to Zinc Binding Sites List in 5sfh
Zinc binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-Amine
Mono view Stereo pair view
Zinc binding site 3 out of 4 in 5sfhGo back to Zinc Binding Sites List in 5sfh
Zinc binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-Amine
Mono view Stereo pair view
Zinc binding site 4 out of 4 in 5sfhGo back to Zinc Binding Sites List in 5sfh
Zinc binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- Cyclopropyl-5-[2-(5,8-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrazin-2-Yl) Ethyl]-N,1-Dimethyl-1,2,4-Triazol-3-Amine
Mono view Stereo pair view
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
Page generated: Mon Oct 28 04:58:09 2024
ISSN: ESSN 1573-4951 PubMed: 36153472 DOI: 10.1007/S10822-022-00478-X |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |